Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards.

ABSTRACT:

Background and introduction

Growing evidence supports a combined modality treatment strategy for patients with oligometastatic disease. However, lack of phase III trial data and uncertainties around patient selection highlight the importance of multidisciplinary tumor boards (MDT) in therapeutic decision-making. This study aimed to analyze the recognition of and treatment recommendations for oligometastatic patients by MDTs at a large comprehensive cancer center in order to better understand current treatment patterns of oligometastasis.

Materials and methods

For this retrospective single-center cross-sectional study, oligometastatic patients were identified by screening oncological PET and concurrent brain MRI scans conducted at our center in 2020. MDT discussions and recom

SUBMITTER: Christ SM 

PROVIDER: S-EPMC9676209 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature